Correlation Between Lantern Pharma and Genenta Science

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lantern Pharma and Genenta Science at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lantern Pharma and Genenta Science into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lantern Pharma and Genenta Science SpA, you can compare the effects of market volatilities on Lantern Pharma and Genenta Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lantern Pharma with a short position of Genenta Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lantern Pharma and Genenta Science.

Diversification Opportunities for Lantern Pharma and Genenta Science

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Lantern and Genenta is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Lantern Pharma and Genenta Science SpA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genenta Science SpA and Lantern Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lantern Pharma are associated (or correlated) with Genenta Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genenta Science SpA has no effect on the direction of Lantern Pharma i.e., Lantern Pharma and Genenta Science go up and down completely randomly.

Pair Corralation between Lantern Pharma and Genenta Science

Given the investment horizon of 90 days Lantern Pharma is expected to under-perform the Genenta Science. But the stock apears to be less risky and, when comparing its historical volatility, Lantern Pharma is 1.21 times less risky than Genenta Science. The stock trades about -0.14 of its potential returns per unit of risk. The Genenta Science SpA is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  409.00  in Genenta Science SpA on November 29, 2024 and sell it today you would lose (16.00) from holding Genenta Science SpA or give up 3.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Lantern Pharma  vs.  Genenta Science SpA

 Performance 
       Timeline  
Lantern Pharma 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Lantern Pharma are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Lantern Pharma displayed solid returns over the last few months and may actually be approaching a breakup point.
Genenta Science SpA 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Genenta Science SpA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Lantern Pharma and Genenta Science Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lantern Pharma and Genenta Science

The main advantage of trading using opposite Lantern Pharma and Genenta Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lantern Pharma position performs unexpectedly, Genenta Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genenta Science will offset losses from the drop in Genenta Science's long position.
The idea behind Lantern Pharma and Genenta Science SpA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data